Osteocytes Acidify Their Microenvironment in Response to PTHrP In Vitro and in Lactating Mice In Vivo

Abstract

Osteocytes appear to mobilize calcium within minutes in response to PTH injections and we have previously shown that osteocytes remove their perilacunar matrix during lactation through activation of the PTH type 1 receptor. Mechanisms utilized by osteocytes to mobilize calcium are unknown but we hypothesized that the molecular components may be similar to those used by osteoclasts. Here we show, using IDG-SW3 cells that ATP6V0D2, an essential component of vacuolar ATPase in osteoclasts, and other genes associated with osteoclastic bone resorption increase with osteoblast to osteocyte differentiation. Furthermore, PTHrP increases ATP6V0D2 expression and induces proton generation by primary osteocytes, which is blocked by bafilomycin, a vacuolar ATPase inhibitor. These in vitro proton measurements raised the question of osteocyte viability in an acidic environment. Interestingly, osteocytes, showed enhanced viability at pH as low as 5 compared to osteoblasts and fibroblasts in vitro. To study in vivo acidification by osteocytes, virgin and lactating CD1 mice on a low calcium diet were injected with the pH indicator dye, acridine orange, and their osteocyte lacuno-canalicular system imaged by confocal microscopy. Lower pH was observed in lactating compared to virgin animals. In addition, a novel transgenic mouse line with a GFPtpz-tagged collagen α2(I) chain was used. Instead of the expected reduction in GFP-fluorescence only in the perilacunar matrix, reduced fluorescence was observed in the entire bone matrix of lactating mice. Based on our experiments showing quenching of GFP in vitro, we propose that the observed reduction in GFP fluorescence in lactating mice is due to quenching of GFP by the acidic pH generated by osteocytes. Together these findings provide novel mechanistic insight into how osteocytes remove calcium from their perilacunar/pericanalicular matrices through active acidification of their microenvironment and show that osteocytes, like osteoclasts, are resistant to the negative effects of acid on viability.

Parathyroid Hormone Signaling in Osteocytes

“…In addition to upregulating cathepsin K and TRAP, PTHrP promotes osteocytic expression of ATP6V0D2, a vacuolar ATPase associated with osteoclastic bone resorption. Indeed, lactating calcium‐deficient mice show reduced perilacunar pH, as assessed using a novel GFP‐based reporter system . PTH/PTHrP‐dependent regulation of perilacunar pH may represent a rapid mechanism for osteocytes to liberate readily accessible pools of calcium.…”

Multiscale bone quality analysis in osteoarthritic knee joints reveal a role of the mechanosensory osteocyte network in osteophytes

“…Osteocytes regulate bone turnover by acting on bone-forming osteoblasts and bone-resorbing osteoclasts 23 . Moreover, osteocytes directly participate in osteolysis 24,25 , control phosphate homeostasis 26 , and functionally act on the neighbouring skeletal muscle 27 and distant organs 28 . Therefore, the integrity of the osteocyte network is important for healthy bone tissue.…”

Regulatory mechanisms and clinical manifestations of musculoskeletal aging

“…Additional factors leading to changes in bone density are dysregulation of hormones (e.g., estrogen and parathyroid hormone) on osteoblasts, osteoclasts, and osteocyte activities, alterations in cellular response to hormones, and vitamin D metabolism . These changes may increase intra‐cortical porosity through remodeling and coalescence of existing cortical canals .…”